menu
Main Data: 31/12 Year 2003 | |
Consolidated statement of income (international practice in accordance with IAS/IFRS) | Millions/Euro |
– total revenues | 351.33 |
– gross margin | 149.54 |
– total operating cost | 105.21 |
– net operating profit | 39.25 |
– financial expenses, netv | 4.01 |
– net income before taxes | 18.96 |
Consolidated balance sheet | Millions/Euro |
– operating capital | 78.20 |
– fixed assets, net | 102.14 |
– reserves and MLT non financial payables | – 13.74 |
– net financial position | – 68.49 |
– stockholders’ equity | 98.11 |
Other Information | Millions/Euro |
– depreciation | 15.65 |
– R & D expenses | 18.21 |
Euro | |
Dividend per share | 0.40 |
No. | |
Employees | 2,400 |
Euro | |
Shares outstanding | 18,772,000 |
Main Data: 30/06 Year 2003 | |
Consolidated statement of income (international practice in accordance with IAS/IFRS) | Millions/Euro |
– total revenues | 143.72 |
– gross margin | 57.82 |
– total operating cost | 54.03 |
– net operating profit | 1.24 |
– financial expenses, net | 0.18 |
– net income before taxes | 0.45 |
Consolidated balance sheet | Millions/Euro |
– operating capital | 92.46 |
– fixed assets, net | 103.05 |
– reserves and MLT non financial payables | – 14.91 |
– net financial position | 85.77 |
– stockholders’ equity | 94.83 |
Other information | Millions/Euro |
– depreciation | 7.58 |
– R & D expenses | 9.60 |
No. | |
Employees | 2,382 |
Euro | |
Shares outstanding | 18,772,000 |
Net Sales by Sector: Year 2003 | ||
Millions/Euro | ||
tea, herbs & coffee | 56.96 | 16.21% |
pharmaceuticals packaging | 208.52 | 59.35% |
pharmaceuticals processing | 85.85 | 24.44% |
Total | 351.33 | 100.00% |
Net Sales by Country: Year 2003 | ||
Millions/Euro | ||
E.U. (excluding Italy) | 146.56 | 41.72% |
Other European countries | 37.37 | 10.64% |
North America | 71.86 | 20.45% |
Asia & Middle East | 37.36 | 10.63% |
Other countries | 28.92 | 8.23% |
Total exports | 322.07 | 91.67% |
Italy | 29.26 | 8.33% |
Total | 351.33 | 100.00% |